全文获取类型
收费全文 | 37540篇 |
免费 | 3126篇 |
国内免费 | 155篇 |
专业分类
耳鼻咽喉 | 645篇 |
儿科学 | 918篇 |
妇产科学 | 675篇 |
基础医学 | 4617篇 |
口腔科学 | 981篇 |
临床医学 | 3458篇 |
内科学 | 8599篇 |
皮肤病学 | 380篇 |
神经病学 | 3378篇 |
特种医学 | 1225篇 |
外科学 | 6257篇 |
综合类 | 741篇 |
一般理论 | 24篇 |
预防医学 | 2895篇 |
眼科学 | 989篇 |
药学 | 2433篇 |
中国医学 | 82篇 |
肿瘤学 | 2524篇 |
出版年
2023年 | 148篇 |
2022年 | 252篇 |
2021年 | 711篇 |
2020年 | 402篇 |
2019年 | 659篇 |
2018年 | 782篇 |
2017年 | 632篇 |
2016年 | 631篇 |
2015年 | 717篇 |
2014年 | 1149篇 |
2013年 | 1614篇 |
2012年 | 2416篇 |
2011年 | 2454篇 |
2010年 | 1355篇 |
2009年 | 1314篇 |
2008年 | 2273篇 |
2007年 | 2409篇 |
2006年 | 2528篇 |
2005年 | 2496篇 |
2004年 | 2332篇 |
2003年 | 2347篇 |
2002年 | 2187篇 |
2001年 | 438篇 |
2000年 | 431篇 |
1999年 | 502篇 |
1998年 | 532篇 |
1997年 | 409篇 |
1996年 | 382篇 |
1995年 | 327篇 |
1994年 | 297篇 |
1993年 | 249篇 |
1992年 | 339篇 |
1991年 | 302篇 |
1990年 | 285篇 |
1989年 | 263篇 |
1988年 | 257篇 |
1987年 | 233篇 |
1986年 | 232篇 |
1985年 | 222篇 |
1984年 | 247篇 |
1983年 | 207篇 |
1982年 | 230篇 |
1981年 | 222篇 |
1980年 | 175篇 |
1979年 | 172篇 |
1978年 | 176篇 |
1977年 | 158篇 |
1975年 | 130篇 |
1974年 | 149篇 |
1973年 | 138篇 |
排序方式: 共有10000条查询结果,搜索用时 8 毫秒
131.
Paul Steinbok Brendon Irvine D. Douglas Cochrane Beverly J. Irwin 《Child's nervous system》1992,8(2):92-96
The long-term functional outcome of 101 children born with meningomyelocele between 1971 and 1981 was assessed, by a combination of retrospective chart review and follow-up assessments. The children had been managed at birth using a process ofnonstandardized selection. Eighty-three of the 101 patients survived after a minimum follow-up of 8.6 years, for a mortality rate of 18%. Forty-four of 83 children (53%) were community ambulators, and this correlated well with the presence of intact quadriceps function. Forty-eight children (58%) attended normal school and were grade-appropriate. Sixty-two of 83 patients (75%) were socially continent of urine, and 71/83 (86%) were socially continent of stool. Hydrocephalus was present in 93 of the 101 children in the study, and 85 children were shunted. Half of the shunted children required a shunt revision in the first year of life, and thereafter the rate of revision decreased, so that after 2 years the risk of revision was approximately 10% per year. 相似文献
132.
133.
Douglas A. Drossman 《Stress and health》1994,10(1):49-55
The irritable bowel syndrome (IBS) is a very common disorder of intestinal function characterized by variable symptoms of abdominal pain, diarrhea, constipation and bloating. The spectrum of severity ranges from mild symptoms, not worthy of clinical attention, to intense and continuous symptoms associated with impaired health-related quality of life and high health care use. Psychosocial disturbance is commonly found among patients with irritable bowel, but until recently, its precise role in the disorder was uncertain. The data now suggest that irritable bowel is not a psychiatric disorder per se, but psychosocial factors including life stress, psychiatric comorbidity and abnormal illness behavior, among others, influence how the illness is experienced and acted upon. Patients with mild symptoms usually respond to education, reassurance, dietary modification and, when needed, antimotility agents. However, patients with more severe symptoms, who usually have greater psychosocial disturbance, will also require behavioral interventions, and possibly psychopharmacological agents. In sum, a graduated, multicomponent plan of care that includes dietary, behavioral and pharmacological treatments is recommended. 相似文献
134.
Douglas Waugh 《Canadian Medical Association journal》1988,139(11):1042
135.
Dr. Douglas N. Fish Pharm. D. Dr. Stephen C. Piscitelli Pharm. D. Dr. Larry H. Danziger Pharm. D. 《Pharmacotherapy》1995,15(3):279-291
The incidence of emergent resistance and clinical factors affecting its development were evaluated by retrospective review of 173 studies encompassing over 14,000 patients. Eight antibiotic classes and 225 individual treatment regimens were evaluated. Emergent resistance occurred among 4.0% of all organisms and 5.6% of all infections treated. It appeared to be significantly more frequent with penicillin and aminoglycoside monotherapy, with significantly lower rates associated with imipenem-cilastatin, aztreonam, and combination therapy. Clinical failure also appeared to be significantly more likely to occur after emergence of resistance among organisms treated with fluoroquinolones or aminoglycosides. Infections associated with higher resistance rates were cystic fibrosis, osteomyelitis, and lower respiratory tract infections. Resistance was most common in patients in intensive care units or receiving mechanical ventilation. It was also significantly frequent among studies performed in university or teaching hospitals. Organisms associated with high resistance rates were Pseudomonas aeruginosa, Serratia, Enterobacter, and Acinetobacter sp. Factors such as infection type, underlying diseases, type of institution, and specific pathogens warrant consideration when examining emergent resistance. 相似文献
136.
Dr. Douglas N. Fish Pharm. D. Ms. Jacquelyn L. Bainbridge B.S. Pharm. Dr. Charles A. Peloquin Pharm. D. 《Pharmacotherapy》1995,15(2):236-245
Continuous arteriovenous hemodiafiltration (CAVHD) is being used increasingly in critically ill patients with acute renal failure (ARF). We prospectively evaluated extracorporeal and total systemic clearances (ClCAVHD and Cls) of ciprofloxacin during CAVHD in four patients with severe ARF to assess the adequacy of drug dosing. Ciprofloxacin serum and ultrafiltrate concentrations were measured by high-performance liquid chromatography. The ClCAVHD accounted for approximately 5.9% (range 2.8–11.6%) of Cls of ciprofloxacin. However, large variability in serum concentrations was observed with the normally recommended dose of 400 mg/day, and doses of up to 800 mg/day were required to maintain concentrations suitable for treatment of serious infections. High daily doses of ciprofloxacin required in these patients are likely related to altered pharmacokinetics in serious illness as well as to the increased extracorporeal clearance during CAVHD. Clinical studies to define appropriate dosing recommendations for ciprofloxacin during CAVHD are necessary to guide clinicians in optimum drug use. 相似文献
137.
138.
139.
140.